N-Succinyl-Ala-Ala-Val p-nitroanilide serves as a chromogenic substrate with a tripeptide core tailored for protease-mapping assays. The nitroaniline reporter enables rapid spectroscopic detection of cleavage events. Researchers apply it to evaluate catalytic specificity and inhibitor behavior. Its succinyl group enhances aqueous compatibility.
CAT No: R2248
CAS No:61043-47-8
Synonyms/Alias:N-Succinyl-Ala-Ala-Val p-nitroanilide;Suc-Ala-Ala-Val-pNA;61043-47-8;MFCD00038473;IFAOJWCXOQHSQT-LXIYXOSZSA-N;FS110738;NS00054211;4-((S)-1-((S)-1-((S)-3-methyl-1-(4-nitrophenylamino)-1-oxobutan-2-ylamino)-1-oxopropan-2-ylamino)-1-oxopropan-2-ylamino)-4-oxobutanoic acid;4-[[(2S)-1-[[(2S)-1-[[(2S)-3-methyl-1-(4-nitroanilino)-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More